BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37522122)

  • 1. Low catestatin as a risk factor for cardiovascular disease - assessment in patients with adrenal incidentalomas.
    Zalewska E; Kmieć P; Sobolewski J; Koprowski A; Sworczak K
    Front Endocrinol (Lausanne); 2023; 14():1198911. PubMed ID: 37522122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol.
    Durakoğlugil ME; Ayaz T; Kocaman SA; Kırbaş A; Durakoğlugil T; Erdoğan T; Çetin M; Şahin OZ; Çiçek Y
    Anatol J Cardiol; 2015 Jul; 15(7):577-85. PubMed ID: 25538000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?
    Moraes AB; Cavalari EMR; de Paula MP; Arruda M; Curi DSC; Leitão RA; de Mendonça LMC; Farias MLF; Madeira M; Vieira Neto L
    J Endocrinol Invest; 2019 Jul; 42(7):797-807. PubMed ID: 30465247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
    Podbregar A; Janez A; Goricar K; Jensterle M
    BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism.
    Lazúrová I; Spišáková D; Wagnerová H; Habalová V; Dravecká I; Darina P; Drahovská I; Pundová L
    Wien Klin Wochenschr; 2011 Oct; 123(19-20):618-22. PubMed ID: 21979884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications.
    Ivović M; Marina LV; Vujović S; Tančić-Gajić M; Stojanović M; Radonjić NV; Gajić M; Soldatović I; Micić D
    Metabolism; 2013 Jun; 62(6):786-92. PubMed ID: 23332445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PENTRAXIN 3 AS A NEW CARDIOVASCULAR MARKER IN ADRENAL ADENOMAS.
    Kizilgul M; Beysel S; Ozcelik O; Kan S; Apaydin M; Caliskan M; Ucan B; Sencar E; Ozdemir S; Cakal E
    Endocr Pract; 2017 Jun; 23(6):662-668. PubMed ID: 28332877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.
    de Paula MP; Moraes AB; de Souza MDGC; Cavalari EMR; Campbell RC; Fernandes GDS; Farias MLF; Mendonça LMC; Madeira M; Bouskela E; Kraemer-Aguiar LG; Vieira Neto L
    J Endocrinol Invest; 2021 Mar; 44(3):609-619. PubMed ID: 32686043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome.
    Emral R; Aydoğan Bİ; Köse AD; Demir Ö; Çorapçıoğlu D
    Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(7):402-409. PubMed ID: 30898604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    Tauchmanovà L; Rossi R; Biondi B; Pulcrano M; Nuzzo V; Palmieri EA; Fazio S; Lombardi G
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension.
    Kumric M; Vrdoljak J; Dujic G; Supe-Domic D; Ticinovic Kurir T; Dujic Z; Bozic J
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum catestatin concentrations are decreased in obese children and adolescents.
    Simunovic M; Supe-Domic D; Karin Z; Degoricija M; Paradzik M; Bozic J; Unic I; Skrabic V
    Pediatr Diabetes; 2019 Aug; 20(5):549-555. PubMed ID: 30714297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of cardiovascular risk factors, carotid intima-media thickness and manifest atherosclerotic vascular disease with carpal tunnel syndrome.
    Shiri R; Heliövaara M; Moilanen L; Viikari J; Liira H; Viikari-Juntura E
    BMC Musculoskelet Disord; 2011 Apr; 12():80. PubMed ID: 21521493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy Risk and Hormonal Activity of Adrenal Incidentalomas in a Large Cohort of Patients from a Single Tertiary Reference Center.
    Cyranska-Chyrek E; Szczepanek-Parulska E; Olejarz M; Ruchala M
    Int J Environ Res Public Health; 2019 May; 16(10):. PubMed ID: 31137898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma.
    Yener S; Genc S; Akinci B; Secil M; Demir T; Comlekci A; Ertilav S; Yesil S
    Endocrine; 2009 Jun; 35(3):365-70. PubMed ID: 19277910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome as a Predictor of Adrenal Functional Status: A Discriminant Multivariate Analysis Versus Logistic Regression Analysis.
    Tsentidis C; Bampilis A; Ntova V; Fragkos D; Panos C; Limniati C; Kassi G
    Horm Metab Res; 2019 Jan; 51(1):47-53. PubMed ID: 30406628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.